Analyst Ratings For Zogenix (NASDAQ:ZGNX)
Today, Leerink Swann reiterated its Outperform rating on Zogenix (NASDAQ:ZGNX).
Some recent analyst ratings include
- 3/4/2018-Leerink Swann Reiterated Rating of Outperform.
- 3/7/2018-Mizuho Reiterated Rating of Buy.
- 11/27/2017-JMP Securities initiated coverage with a Outperform rating.
- 9/29/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 9/29/2017-William Blair Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 3/11/2017-Aegis Reiterated Rating of Buy.
- 9/21/2016-Brean Capital Reiterated Rating of Buy.
- On 12/13/2017 Bradley S. Galer, EVP, bought 1,346 with an average share price of $36.59 per share and the total transaction amounting to $49,250.14.
- On 12/11/2017 Roger Hawley, Director, sold 63,203 with an average share price of $36.84 per share and the total transaction amounting to $2,328,398.52.
- On 12/8/2017 Roger Hawley, Director, sold 11,797 with an average share price of $37.02 per share and the total transaction amounting to $436,724.94.
- On 10/3/2017 Life Sciences Maste Perceptive, Major Shareholder, bought 300,000 with an average share price of $37.50 per share and the total transaction amounting to $11,250,000.00.
- On 9/29/2017 Life Sciences Maste Perceptive, Major Shareholder, bought 222,055 with an average share price of $32.83 per share and the total transaction amounting to $7,290,065.65.
- On 6/30/2017 Life Sciences Maste Perceptive, Major Shareholder, bought 175,653 with an average share price of $14.45 per share and the total transaction amounting to $2,538,185.85.
- On 3/16/2017 Renee P Tannenbaum, Director, bought 5,000 with an average share price of $11.00 per share and the total transaction amounting to $55,000.00.
Recent Trading Activity for Zogenix (NASDAQ:ZGNX)
Shares of Zogenix closed the previous trading session at 44.10 up +0.10 0.23% with 66391 shares trading hands.